Company ProfilePremium

BioSmart Co., Ltd.

Company Profile Analysis

Ticker: 038460.KQ주

ESOMAR 23 Corporate BadgeISO Certifications Badge
BioSmart Co., Ltd. - Company showcase

Year Founded & Workforce

1971

169 Employees

BioSmart Co., Ltd. logo

BioSmart Co., Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

BioSmart Co., Ltd. Overview

BioSmart began as a domestic payment-card manufacturer. Over roughly 20 years under its controlling shareholder, Chairman Park Hye-rin, it has turned into a diversified, acquisition-built mini-conglomerate. The founding business makes and personalizes credit, check, IC, metal and access cards for Korean card issuers. Since 2022, however, consolidated revenue has been dominated by copper winding wire made by its 47.6%-owned, separately listed subsidiary TC Materials. That business supplies continuously transposed conductor (CTC), flat (rectangular) copper wire and enamelled wire to transformer, cable and EV-component makers. Smaller segments cover generic pharmaceuticals (Austin Pharm), liquor-trade payment and ERP systems (Bona), and publishing. BioSmart also holds stakes in listed affiliates Omni System and The Lami and in an English-education business (Wall Street Institute Korea). The investment case rests on the power-grid copper cycle running through TC Materials. The discount rests on thin margins, opaque group governance and an absence of shareholder returns. In October 2026 the stock traded at about 0.45x book value.


Company's own description (paraphrased from DART business-report summaries)

The DART-derived summary published by DataHero/ValueLine describes BioSmart as follows. Smart-card manufacturing is its core activity, alongside pharmaceuticals, liquor-payment services, book publishing, and heavy-electrical/copper products.

  • The smart-card business claims domestic market leadership. It makes credit cards, metal cards, IC cards and access cards.

  • The pharmaceutical business carries about 300 products. The split is roughly 60% prescription (ETC) and 40% over-the-counter (OTC).

  • The liquor-payment business provides the liquor purchase-only card, liquor-distribution ERP and the National Tax Service (NTS) liquor-distribution information system. It describes itself as a leader in that niche.

  • Publishing covers trade books, a "Sigong" magazine and a book club.

  • The heavy-electrical/copper business makes flat copper wire for transformers and rotating machines and manufactures and repairs motor stators.

Management frames the diversification as a hedge against the maturity of its original business, seeking synergy by combining unrelated industries.

A separate data provider (RiskWeather) also lists diagnostic kits, continuously transposed windings and turbine-generator work among the activities.

Independent characterization

In substance, BioSmart is now a holding-style operating company. Its consolidated P&L is driven by an industrial copper-processing subsidiary, not by cards.

On the 2Q 2026 revenue basis shown by Butler, the mix was:

An earlier Butler snapshot for the same period showed 72/17/8/2/1. The economics therefore follow copper prices, the cost of passing copper through to customers, and the Korean and US transformer and cable capex cycle more than card-issuance volumes.

The standalone parent (the card business plus head office) generated KRW 103.3B of revenue in FY2025 with 168 employees (DART via ETF Shopping). That is only about 21% of consolidated revenue of KRW 482.8B.

Business and revenue model

DimensionCharacterization
Revenue typePredominantly product sales (copper wire, cards, drugs). There are service and transaction elements in card personalization and issuing services, liquor-payment/ERP services and publishing. No material subscription or licensing revenue is disclosed.
Value-chain positionCopper: mid-stream processor. It converts purchased copper rod/cathode into engineered conductors for OEMs (HD Hyundai Electric, Hyosung Heavy Industries, Iljin Electric, LS Cable, Taihan Cable, Samsung Electronics, Hyundai Motor). Cards: contract manufacturer and personalizer for card issuers, using third-party chip operating systems (a 2010s trade report grouped BioSmart with makers that rely on foreign COS, as opposed to vertically integrated COS developers such as KONA I and UbiVelox). Pharma: generic ETC/OTC manufacturer and marketer.
Customer typesB2B: card issuers and banks; transformer, cable and EV-component makers; pharmacies and hospitals via distributors and CSOs; liquor wholesalers and retailers; book consumers (B2C).
End-marketsPayments/financial services; power transmission and distribution; electric vehicles; home appliances; healthcare; the liquor trade; publishing; education (affiliate).
Pricing mechanics (copper)Prices are copper-linked with a pass-through. Timing mismatches compress margins when copper rises: TC Materials' 2Q26 operating margin fell to 3.1% from 6.3% in 1Q26 because customers reflected copper prices at different times (DS Investment, Sept 2026).

Strategy

Stated strategy

The DART business report (as summarized) frames the strategy as cross-industry combination. Its stated aim is to hedge the risks of operating in mature industries and to create synergies across unrelated businesses.

In practice, the strategy has been serial acquisition of distressed or undervalued companies, followed by operational normalization. Examples:

  • KBC (2004, after the card crisis).

  • Omni System (2009, after the financial crisis).

  • Austin Pharm (2016, after a trust crisis).

  • TC Materials (2021–23, through rehabilitation).

  • The Lami (2023, during a trading suspension).

  • WSI Korea (2024).

Dealsite (April 2026) reports that Park prefers to demonstrate value through earnings rather than short-term share-price support. The Lami's management said it was not considering shareholder returns for now.

Initiatives in the last 24 months

InitiativeDateDetailStatus
TC Materials KOSDAQ listing (SPAC)15 May 2025Crystallized a listed value for the copper subsidiary. IPO guidance was KRW 359.2B revenue and KRW 17.9B operating profit.FY2025 actual: KRW 299.1B / KRW 6.8B, an operating-profit miss of about 60% (Dealsite)
TC Materials capacity expansionAnnounced Dec 2025Flat wire + CTC capacity rising from 12,400 t to 21,200 t; enamel wire to 17,400 t; EHV materials to 7,000 tCTC lines to 13 by Oct 2026 (DS Investment)
Superconducting wire national R&D projectFeb 2026Reported near completionCommercialization not disclosed
WSI Korea control2024–2026Stake bought (45.9% for about KRW 1.3B), diluted to the 30% range, then lifted via loan-to-equity conversion (43.61%)Rationale undisclosed; company declined comment (Dealsite)
Treasury share elimination1H 2026KRW 3.0B treasury stock removed; issued shares from about 26.16M to 25.27MCompleted per balance-sheet data
Group "value-up" pressure2,026Affiliates face tighter delisting rules for low-priced stocks; Omni System cancelled treasury shares (Apr 2026) and approved a 5:1 reverse split (Oct 2026)In progress
Eco-friendly cards / de-plastic positioningOngoingPatents for paper diagnostic-kit panels and eco card materialsProduct-level revenue not disclosed

Guidance and medium-term targets

EntityTarget / forecastSourceStatus
TC MaterialsFY2025 guidance KRW 359.2B revenue / KRW 17.9B operating profit (given at listing)DealsiteMissed
TC MaterialsThird-party forecast: operating profit KRW 21.3B (2026), KRW 36.7B (2027)DS Investment, Sep 2026Not company guidance
Austin PharmKRW 100B revenue by 2024, incl. KRW 20B+ OTC (stated 2021–22)Daily PharmAchievement not disclosed; pharma's roughly 7% share of group revenue suggests it was not met (analyst inference)

BioSmart provides no public guidance and no medium-term financial targets. Subsidiary-level targets:

ESG and sustainability commitments: not publicly disclosed.

Products & Services

Cards (BioSmart parent)

Product / serviceDescription and capabilitiesTarget customerNotes
Magnetic-stripe (MS) cardsCredit-card-size plastic cards with magnetic stripeCard issuers, retailers, membership programsLegacy product (S&P / Morningstar)
Contact IC cardsEmbedded microprocessor/memory chip; EMV-capableBanks, card issuersUses third-party chip OS
Contactless and combi (dual-interface) cardsRF interface for tap payments and transitIssuers, transitGlobal contactless share of payment-card shipments reached 92% in 2024 (Smart Payment Association, via GII)
Metal cardsPremium metal-bodied payment cardsPremium card programsListed by DART as a key product
Eco-material cards (incl. hanji paper card)Cards in non-plastic or eco materials. BioSmart reports converting several issuers' plastic cards to eco materials.ESG-sensitive issuersCited when the stock rallied on de-plastic policy news (Asia Economy, Apr 2025)
RFID, 3D lenticular and bio cardsSpecialty cardsCorporate, ID, promotionalMorningstar description
ID / access cardsEmployee and access credentialsCorporates, institutionsDART summary
Card-issuing equipmentTransit and smart-card issuing machinery; credit-card issuing machinery (encoding, embossing, indent)Issuers, bureausS&P / CB Insights
Personalization servicesMS encoding, IC-chip personalization, photo transferIssuersS&P
Issuing softwareSoftware for credit-card issuingIssuers, bureausS&P

Pricing models are not publicly disclosed.

Heavy-electrical / copper products (TC Materials)

ProductDescriptionEnd-use / customersCapacity / notes
CTC (continuously transposed conductor)Multi-strand transposed copper conductor for transformer windings, from medium voltage to extra-high voltage; oxygen-free grades for EHVHD Hyundai Electric, Hyosung Heavy Industries, Iljin ElectricLines going from 5 to 13 by Oct 2026; output to about 1,600 t/month, more than 3x prior (DS Investment, Sep 2026). Planned 2026 capacity 13,200 t (Asia Economy, Dec 2025).
Flat (rectangular) copper wireRectangular wire for transformers and rotating machines; Korea-first subsea-cable grade (May 2025)Transformer and cable makersPlanned 2026 capacity 8,000 t (flat wire + CTC combined: 12,400 t in 2025 rising to 21,200 t in 2026)
Enamelled copper wireInsulated magnet wire. Korea-first development for subsea-cable and EHV power-cable materials.Cable makers (LS Cable, Taihan), appliances, EV componentsCapacity 15,000 t rising to 17,400 t
EHV cable materialsCopper materials for extra-high-voltage cableLS Cable, Taihan CableCapacity 6,000 t rising to 7,000 t
Motor stators / repairStator manufacture and repair; turbine-generator and rotating-machine workUtilities, industrialsDART summary; RiskWeather
Superconducting wire (development)Government (national R&D) project reported near completion in Feb 2026Future grid applicationsFinance Scope headline (Feb 2026)

At listing (May 2025), power-sector products were 96.9% of TC Materials' sales, and power infrastructure was more than 60% of product sales (Finance Scope).

Pharmaceuticals (Austin Pharm)

LineDescriptionNotes
ETC (prescription) genericsAbout 60% of the roughly 300-product portfolioUBIST prescription value rose from KRW 7.3B (2016) to KRW 48.3B (2021) (Daily Pharm)
OTCAbout 40% of the portfolioSamsung Pharm co-promotion of 11 OTC products (Dec 2021); FY2024 OTC target of KRW 20B+ (2022 statement)
ManufacturingAnsan, Gyeonggi-do plantDaily Pharm (Jun 2022)

Named flagship brands are not disclosed in retrieved sources.

Liquor payment (Bona)

OfferingDescription
Liquor purchase-only card (주류구매전용카드)Debit-style card mandated since 2001 for wholesaler–retailer liquor transactions; transaction data are reported to the NTS
NTS-linked credit-card settlementLaunched with KCP (Korea Cyber Payment) in June 2014, through "Bona Bank", to allow deferred payment
Liquor-distribution ERPERP for liquor wholesalers
NTS liquor-distribution information systemSystem services linked to the NTS traceability regime
GetJu (겟주) smart-order appConsumer liquor smart-order service. TheVC lists a press headline indicating the service ended.

Bona Networks: founded August 2000; CEO Yoon Ho-kwon; 49 employees (Feb 2026); 6 patents (TheVC).

Publishing

Trade books, the Sigong magazine and a book club (DART summary). Titles, revenue and pricing are not publicly disclosed in retrieved sources.

Financial Narrative

Source: S&P Global Market Intelligence via StockAnalysis.com (annual, FY2021–FY2025; KRW millions). DART-based aggregator figures are shown where they differ.

Income statement

DART-basis operating income and net income are from ETF Shopping / Butler (KRW 100M units converted to KRW M). The FY2022–23 operating-income gaps reflect classification differences between S&P and DART.

Dividends per share. No dividend was declared for FY2022–FY2025. Cash dividends of KRW 360M were paid in FY2022 (payout ratio 49.9% on FY2022 earnings, S&P).

Revenue CAGR (analyst calculation): FY2021–FY2025 is 26.4% a year, almost entirely acquisition-driven. FY2022–FY2025, the organic-ex-TC-consolidation proxy, is 7.2% a year.

Quarterly trajectory (DART, via ETF Shopping)

The trailing twelve months to June 2026 (S&P) show:

1H26 revenue of KRW 312.9B was up 34.2% on 1H25 (KRW 233.1B); 1H26 operating income of KRW 15.2B was up 55% (analyst calculation from quarterly data).

Balance sheet

At March 2026, total debt was KRW 77.7B (short-term KRW 47.0B, long-term KRW 27.0B, leases KRW 3.7B), cash and short-term investments KRW 25.7B, and net debt KRW 51.9B (S&P).

Ratios

Interest coverage and DIO are analyst calculations from S&P data. A full cash conversion cycle cannot be computed: from FY2024, S&P reclassifies trade receivables into "other current assets", which breaks the receivables series. Receivable days are therefore not publicly disclosed on a consistent basis.

Commentary on trends and drivers

Scale versus quality. Consolidating TC Materials (from FY2022) changed the group's profile. Revenue roughly doubled, but gross margin fell from 36% to the high teens because copper processing is a low-margin, pass-through business. The fall reflects mix: the high-margin card business was diluted by copper volumes. Underlying deterioration is not the main driver.

Operating inflection in FY2024–FY2025. Operating income roughly doubled in FY2024 (S&P: KRW 9.8B to KRW 19.5B; DART: KRW 10.1B to KRW 20.2B). It rose again in FY2025 to KRW 22.7B on flat revenue, with SG&A held at about KRW 59B against KRW 62.5B in FY2023. 1H26 shows strong top-line acceleration (+34%), led by TC Materials (+55%). The 2Q26 margin dip came from timing in copper price pass-through.

Earnings quality is noisy. Below the operating line, results swing on equity-method income, impairments and one-off gains:

  • FY2023 net income of KRW 17.9B included a KRW 15.9B gain on sale of investments.

  • FY2024 attributable net income was nearly zero (KRW 0.1B) despite KRW 19.5B of operating income. The causes were KRW 5.0B of other unusual items, KRW 1.9B of asset write-downs, KRW 4.6B of other non-operating losses and an 85% effective tax rate.

  • Reported ROE has therefore ranged from -1.2% to 14.7% with no clear relationship to operations.

Cash conversion is weak and investment has stepped up. Operating cash flow was KRW 1–6B a year in FY2021–FY2024, far below EBITDA, as working capital absorbed KRW 9–15B a year. FY2025 OCF improved sharply to KRW 24.1B. Capex jumped to KRW 33.2B, however, and land on the balance sheet rose from KRW 23.6B to KRW 44.4B. The result was negative free cash flow (-KRW 9.2B FY2025; -KRW 22.3B TTM to Mar-26).

Deleveraging, then re-leveraging. Net debt / EBITDA fell from 4.3x (FY2021) to 1.2x (FY2025). Drivers were higher EBITDA, KRW 24.6B of divestiture proceeds in FY2023, and the TC Materials SPAC listing, which raised NCI equity from KRW 27.0B to KRW 43.7B. Net debt then climbed back to KRW 51.9B by March 2026 as capex and working capital absorbed cash. Short-term debt dominates the borrowing structure, which creates refinancing exposure.

Minority leakage. Non-controlling interests rose from -KRW 7.5B (FY2021) to KRW 46.2B (Mar-26). This reflects TC Materials' public float and other partly owned subsidiaries. Minority interests absorbed KRW 4.8B of TTM earnings to Jun-26, so a growing share of consolidated profit is not attributable to BioSmart shareholders.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentShare of revenue % (2Q26, Butler snapshot A)Share of revenue % (2Q26, Butler snapshot B)

Heavy-electrical / copper products

7472

Cards

1617

Pharmaceuticals

78

Liquor payment

32

Publishing

11

Heavy-electrical / copper

TC Materials Co., Ltd. (KOSDAQ 125020; 47.61% owned at end-2025)

CTC for transformers; flat (rectangular) copper wire incl. a subsea-cable grade; enamelled copper wire; extra-high-voltage cable materials; motor stator manufacture and repair

Cards

BioSmart Co., Ltd. (parent)

Magnetic-stripe, contact, contactless and dual-interface (combi) IC cards; metal cards; RFID and 3D lenticular cards; ID/access cards; card-issuing equipment and software; MS/IC personalization and photo transfer

Pharmaceuticals

Austin Pharm Co., Ltd. (80.6% at end-2025)

About 300 generic ETC/OTC products (ETC 60% / OTC 40%)

Liquor payment

Bona entities (Bona Networks, formerly Bona Bank; Bona Camp 86.18% owned)

Liquor purchase-only card; liquor-distribution ERP; NTS liquor-distribution information-system services; NTS-linked credit-card settlement

Publishing

Group publishing affiliate. Daily Pharm (2022) names Sigongsa as the group's "cultural content" company.

Trade books, Sigong magazine, book club

Investee Details

InvesteeStake %Latest total assets (KRW Bn)Latest net income (KRW Bn)Notes

Omni System (KOSDAQ 057540)

23.36132.56.72

Digital meters/AMI; acquired 2009

Bona Camp

86.1823.0-1.93—

The Lami (KOSDAQ 032860)

28.2961.82.48

Formerly Human N; acquired 2023

TC Materials (KOSDAQ 125020)

47.6176.26.27

Copper winding wire

Austin Pharm

80.6041.30.20

Generic pharma

Wall Street Institute Korea

43.61——

English education

Horizon IM

9.90——

Not described

T-money (Korea Smart Card)

0.37729.128.5

Transport card operator (financial investment)

Solidus Smart Bio Investment Fund

0.50——

VC fund

IBKC-Gaia MSP New Technology Fund No.1

5.00——

VC fund

2014 Solidus Growth Ladder Startup Fund

2.09——

VC fund

SGI Unicorn Startup Fund

1.70——

VC fund

“—” = not publicly disclosed.

Income Statement and Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Revenue (KRW Mn)

189,183391,822456,164484,310482,776

Revenue growth (%)

13.67107.1116.426.17-0.32

Gross profit (KRW Mn)

68,43676,72979,00682,26285,256

SG&A (KRW Mn)

56,11461,16762,45258,51559,480

R&D expense (KRW Mn)

426.861,1681,341680.12692.89

Operating income, S&P basis (KRW Mn)

7,9609,3029,75819,46022,663

Operating income, DART basis (KRW Mn)

8,00010,20010,10020,20022,600

EBITDA (KRW Mn)

13,59118,87418,24727,66430,098

Interest expense (KRW Mn)

2,0414,3965,9624,6382,857

Pre-tax income (KRW Mn)

1,3411,95621,1787,06114,724

Income tax (KRW Mn)

707.13,1374,9986,0055,738

Net income incl. NCI, DART basis (KRW Mn)

600-1,20016,2001,1009,000

Net income attributable to owners (KRW Mn)

1,392721.3117,907127.179,009

EPS basic (KRW)

72.5337.57915.155.61356.45

EPS diluted (KRW)

72.5337.57556.835.61356.00

Effective tax rate (%)

52.73160.4323.6085.0538.97

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Margin Analysis (%)

MetricFY2021FY2022FY2023FY2024FY2025

Gross margin (%)

36.1819.5817.3216.9817.66

Operating margin (%)

4.212.372.144.024.69

EBITDA margin (%)

7.184.824.005.716.23

Net margin, attributable (%)

0.740.183.930.031.87

Financial Analysis

Metric1Q242Q243Q244Q241Q252Q253Q254Q251Q262Q26

Revenue (KRW Bn)

118.7130.1119.1116.5112.3120.8125.5124.2145.3167.6

Operating income (KRW Bn)

4.35.03.87.25.64.27.65.110.15.1

Net income incl. NCI (KRW Bn)

4.9-4.7-1.52.42.8-2.84.94.07.22.2

TTM Metric Details

TTM metric (to Jun-26)Value

Revenue

KRW 562.7B (+20.1%)

Operating income

KRW 28.1B (margin 5.0%)

EBITDA

KRW 34.8B

Net income attributable

KRW 13.5B

EPS

KRW 533.65

Balance Sheet and Per-Share Data

MetricFY2021FY2022FY2023FY2024FY2025

Total assets (KRW Mn)

225,851237,183260,063262,843309,881

Cash and equivalents (KRW Mn)

13,58519,61220,85110,81230,022

Cash and short-term investments (KRW Mn)

15,27420,28231,34320,84239,111

Inventory (KRW Mn)

50,77457,05153,02250,44852,356

Property, plant and equipment (KRW Mn)

52,86650,08045,02948,81876,845

Long-term investments (KRW Mn)

33,91034,19452,27555,37556,675

Goodwill and intangibles (KRW Mn)

6,2197,1817,1927,4747,648

Short-term debt incl. current LTD and leases (KRW Mn)

40,54672,32972,61739,58646,031

Long-term debt incl. leases (KRW Mn)

33,06811,25216,10124,81129,888

Total debt (KRW Mn)

73,61483,58188,71864,39775,919

Net debt (KRW Mn)

58,34063,29857,37543,55536,808

Total liabilities (KRW Mn)

131,220141,878135,431104,394122,224

Equity attributable to owners (KRW Mn)

99,09896,725111,691129,484143,993

Non-controlling interests (KRW Mn)

-7,467-4,4209,94126,96443,664

Total equity (KRW Mn)

94,63195,305124,632158,449187,657

Working capital (KRW Mn)

30,4981,46617,98256,47963,994

Book value per share (KRW)

5,161.945,038.315,473.195,123.115,697.14

Cash Flow

MetricFY2021FY2022FY2023FY2024FY2025

Operating cash flow (KRW Mn)

1,2036,2891,1663,70824,073

Capital expenditure, outflow (KRW Mn)

5,3324,3593,1136,92233,245

Free cash flow (KRW Mn)

-4,1291,930-1,947-3,213-9,172

Cash acquisitions, outflow (KRW Mn)

26,7480000

Divestiture proceeds (KRW Mn)

04,00024,64600

Dividends paid (KRW Mn)

0360000

Share repurchases (KRW Mn)

00009.3

Equity issued (KRW Mn)

5,850007,9960

Net debt issued / repaid (KRW Mn)

18,7466,5536,060-19,15721,233

Change in working capital (KRW Mn)

-12,907-8,574-15,403-12,859-969.51

Returns & Leverage Ratios (%) and Financial Ratios (x)

MetricFY2021FY2022FY2023FY2024FY2025

ROE (%)

0.68-1.2414.710.755.19

ROA (%)

2.532.512.454.654.95

ROIC (%)

2.83-3.614.381.526.49

ROCE (%)

5.808.506.8010.5010.30

Current ratio (x)

1.351.011.151.731.71

Quick ratio (x)

0.640.480.610.270.44

Debt / equity (x)

0.780.880.710.410.41

Net debt / EBITDA (x)

4.293.353.141.571.22

Interest coverage, EBIT / interest (x)

3.902.121.644.207.93

Asset turnover (x)

0.961.691.841.851.69

Inventory turnover (x)

2.745.856.857.777.73

Days inventory outstanding (days)

13362534747

Operating Areas

AreaRecent trendSource

Power infrastructure (TC Materials)

Fastest growing: +73.5% YoY in 1Q26 on CTC, flat wire and EHV cable materials

Hankyung / Newsis (May 2026)

EV components (TC Materials)

+60.1% YoY in 1Q26, helped by customer diversification

Hankyung / Newsis (May 2026)

Home appliances and other (TC Materials)

Declining: -17.4% YoY in 1Q26 on weak global appliance demand

Hankyung / Newsis (May 2026)

Cards, pharma, liquor payment, publishing

Share of revenue falling as copper grows; absolute trends not disclosed

Butler

Capital Markets Data (KRW) and Market Valuation

MetricFY2021FY2022FY2023FY2024FY2025

Year-end close (KRW)

5,7103,3303,4253,0803,900

Year-end market cap (KRW Mn)

109,62063,92969,89477,84698,571

Year-end enterprise value (KRW Mn)

118,178123,843156,095156,743160,681

Change by Period

PeriodChange (%)Basis

Year-to-date 2026 (from 3,900 to 2,685)

-31.2

Analyst calculation

6 months

-38.6

ValueLine, 15 Oct 2026

52 weeks to 10 Aug 2026

-10.8

S&P

Since FY2023 close (3,425)

-21.6

Analyst calculation, about 3 years

Since FY2021 close (5,710)

-53.0

Analyst calculation, about 5 years

Other trading data

Value

—

52-week range

KRW 2,305 – 6,930 (StockHub, Oct 2026)

—

Beta (5-year)

0.73—

50-day / 200-day moving average

KRW 2,697.6 / KRW 3,596.7 (S&P, 10 Aug 2026)

—

Float

18.58M shares

—

Average volume (20-day)

About 119,000 shares

—

Valuation Multiples (x)

MetricFY2021FY2022FY2023FY2024FY2025

P/E (x)

78.7288.633.90612.1310.94

P/B (x)

1.160.670.560.490.53

EV/EBITDA (x)

8.706.568.555.675.34

EV/Sales (x)

0.630.320.340.320.33

Valuation Snapshot

MultipleValueBasis

P/E

About 5.0x

TTM attributable net income KRW 13.5B (Butler: 5.03x; ValueLine: 5.05x)

P/B

About 0.45x

Common equity KRW 148.7B, Mar-26

EV/EBITDA

About 4.8x

EV about KRW 166B / TTM EBITDA KRW 34.8B (ValueLine shows 3.70x on its own definition)

EV/Sales

About 0.30x

TTM revenue KRW 562.7B

Holding Details

HoldingMarket cap used (KRW Bn)Stake %Value to BioSmart (KRW Bn)

TC Materials

171.5 (22 Jul 2026)

47.61

About 81.7

Omni System

54.6 (21 Jul 2026)

23.36

About 12.8

The Lami

24.0 (31 Jul 2026)

28.29

About 6.8

Total listed stakes

——

About 101

Capital Markets

ItemStatus

Analyst consensus

None. Zero sell-side reports (StockHub); no consensus estimates (Investing.com, Stockopedia).

Dividend history and policy

KRW 360M paid in FY2022 (payout 49.9%); no dividends FY2023–FY2025; no published dividend policy. Stockopedia confirms no current dividend.

Buybacks

KRW 9.3M repurchased in FY2025; treasury stock (KRW 3.0B) eliminated in 1H26. No buyback authorization disclosed.

Share count history

Basic weighted shares: 19M (FY2021–22), 20M (FY2023), 23M (FY2024), 25M (FY2025). Dilution came from equity issuance and conversions. Last stock split: 1-for-6 reverse, 20 Sep 2010.

Credit ratings (Moody's / S&P / Fitch)

None; not rated by international agencies. Domestic ratings not publicly disclosed.

Debt maturity profile (Mar-26)

Short-term borrowings KRW 47.0B (due within 12 months); long-term debt KRW 27.0B; leases KRW 3.7B. A detailed maturity ladder is not publicly disclosed in retrieved sources.

Credit-health scores

Altman Z-Score 2.86 (below the 3.0 safe threshold); Piotroski F-Score 4 (S&P)

Analyst Conclusions

Management guidance and consensus

BioSmart issues no guidance and has no consensus. The only forward-looking third-party figures are DS Investment's operating-profit forecasts for subsidiary TC Materials: KRW 21.3B in 2026 and KRW 36.7B in 2027. The 2026 figure is triple TC's FY2025 standalone operating profit of KRW 6.8B. The 2027 figure assumes full ramp of 13 CTC lines and better product mix.

1H26 group revenue of KRW 312.9B (+34%) puts FY2026 on a path to roughly KRW 600B+ if 2H26 holds at 1H26 levels. This is an analyst extrapolation, not guidance.

Bull case

  1. Grid-cycle operating leverage. TC Materials is tripling CTC output into a transformer upcycle. If DS Investment's KRW 36.7B 2027 operating-profit forecast for TC is approached, consolidated operating income could rise well above FY2025's KRW 22.7B. The 1Q26 group operating margin was already 7.0%.

  2. Discount to listed holdings. BioSmart's listed stakes are worth about KRW 101B at mid-2026 prices, versus a KRW 67.9B market cap. The operating card business and land holdings (KRW 44.4B) also sit beneath that. Any value-up action — dividends, further cancellation, IR — could narrow the gap. The 1H26 treasury-stock elimination is a first step.

  3. Balance-sheet repair already done. Net debt / EBITDA fell from 4.3x to 1.2x (FY2021–FY2025). TTM ROCE is 11.9%. At about 5x P/E and 0.45x P/B, a modest rerating to 0.7x book (the five-year average P/B is 0.74x, per ValueLine) would imply more than 50% upside.

Bear case

  1. Earnings do not reach shareholders. Attributable net income was KRW 0.1B in FY2024 despite KRW 19.5B of operating income. Minorities absorbed KRW 4.8B of TTM profit, and FCF was -KRW 22.3B TTM. Growth is consuming cash rather than producing it.

  2. Credibility and governance. TC Materials missed its first-year IPO operating-profit guidance by about 60%. Group affiliates face delisting-threshold pressure. Capital allocation includes opaque moves such as the WSI Korea loan-to-equity conversion, with the rationale undisclosed. There is no IR program. The discount may be structural rather than temporary.

  3. Copper and concentration risk. Margins are hostage to copper pass-through timing (2Q26 TC margin 3.1%) and to a few customers (top-3 about 50%). A slowdown in transformer orders or adverse copper moves would hit volume and margin together.

Catalysts and monitorables (next 12 months)

MonitorableWhy it matters
3Q26 report (due by mid-November 2026)Whether TC Materials' margin recovers from 3.1% as copper pass-through renegotiation (current-month copper pricing) takes effect
Completion and ramp of the 13-line CTC capacity (Oct 2026)Monthly output about 1,600 t
FY2026 business report (about March 2027)Segment profit disclosure; FCF; capex purpose (land and buildings); dividend decision
Omni System reverse split (20 Oct 2026) and The Lami priceDelisting-rule compliance
Further shareholder-return measuresDividend reinstatement or further share cancellation
Insider ownership filingsDirection of controlling-group trades (filings in Jul–Sep 2026)
Group capital allocationAny new M&A or intra-group transactions (WSI Korea funding)

Analyst verdict

BioSmart is no longer a card company. It is a thinly capitalized, founder-controlled holding vehicle whose consolidated numbers are driven by a single listed copper-materials subsidiary. The operational story has improved materially:

  • Operating income more than doubled between FY2023 and FY2025.

  • Leverage has halved.

  • 1H26 revenue grew 34%, carried by TC Materials' exposure to transformer and EHV-cable demand.

Taken alone, these trends and a share price at about 5x earnings and 0.45x book would suggest a mispriced asset.

The market's skepticism nevertheless has a factual basis. Reported earnings have repeatedly failed to translate into attributable profit or free cash flow. FY2024 attributable net income was essentially zero, and TTM free cash flow is deeply negative after a KRW 33B capex step-up whose purpose is not transparently communicated. The flagship subsidiary missed its listing guidance badly in its first year. Two other listed affiliates are fighting low-price delisting thresholds. Shareholder returns have been negligible since 2022, and there is no investor-relations framework, sell-side coverage or forward guidance to anchor expectations. The persistent holding discount — listed stakes alone exceed the parent's market value — is therefore partly a governance discount that will not close by itself.

Our assessment is that BioSmart offers asymmetric but low-conviction value. The principal swing factor is TC Materials delivering on its capacity ramp with restored margins (5–6% operating margin or better) through 2027. The principal unlock would be an explicit capital-return policy from the controlling shareholder. Absent the second, the first may continue to accrue mainly to TC Materials' minority holders and to further group expansion rather than to BioSmart shareholders.

Classification: deep-value / special-situation. Key confirmation points: 3Q26 margin recovery at TC Materials and any dividend or buyback announcement with the FY2026 results.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleTenure / backgroundAge2025 compensation

Park Hye-rin (박혜린)

Chairman; controlling shareholder (19.91%)

Acquired the predecessor KBC in 2004 and has controlled the group for more than 16 years. Earlier business: tyre imports from 1993. Also inside director/CEO across listed affiliates (Omni System, TC Materials; The Lami from 2026). Non-standing director of WSI Korea. Described by Korean media as an M&A specialist.

Born 1968 (Dealsite)

KRW 850M total (DART 2025; split between salary and bonus not disclosed in retrieved sources)

Yoon Ho-kwon (윤호권)

CEO / Representative Director; styled Vice-Chairman

Related party holding 3.77%. CEO of Bona Networks. Was a non-standing director at TC Materials before the 2025 move to inside director. Non-standing director at WSI Korea.

—

KRW 830M total (DART 2025)

Han Kyung-taek

Chief Financial Officer

——

Below disclosure threshold

"Ho-Gwon Yoon"

Chief Operating Officer (per S&P)

———

Hyun Byung-taek (현병택)

Group vice-chairman; CEO of bio division / Austin Pharm (appointed Apr 2021)

Former deputy president, IBK Industrial Bank.

——

“—” = not publicly disclosed.

Governance Overview

ItemDetail

Registered directors/auditors

4 (DART 2025 pay disclosure basis)

Independence, committees, chair/CEO separation

Not publicly disclosed in retrieved sources. Chair (Park) and CEO (Yoon) are separate individuals but closely aligned; both are in the controlling group.

Group-level governance concerns

Dealsite (Jul 2025) noted that appointing both Park and Yoon as inside directors at TC Materials would push its outside-director ratio below the 25% legal minimum, requiring a board reshuffle. Dealsite (Apr 2026) characterized the group as lacking shareholder-return policies and IR, which it ties to persistent undervaluation.

Board & Management Changes

DateChange

Apr 2021

Hyun Byung-taek joins as group vice-chairman

Jul 2025

Park Hye-rin returns to the TC Materials board as inside director (EGM agenda); Yoon Ho-kwon moves from non-standing to inside director (Dealsite)

c. Apr 2026

Park Hye-rin takes direct leadership of The Lami (Dealsite)

Major Shareholders

HolderStake % (end-2025)

Park Hye-rin

19.91

Yoon Ho-kwon

3.77

Witz Energy (위지트에너지)

1.01

Lim Jong-il

0.03

Controlling group total

24.72

Minority shareholders (16,375 holders)

61.62

Insiders (S&P definition)

25.43

Institutions (S&P)

4.50

Competitive Landscape

Competitors by Segment

SegmentCompetitorPositioning versus BioSmartData

Cards

KONA I (KOSDAQ 052400)

Korea's leading smart-card and COS company; vertically integrated (own COS); about 100M cards a year of capacity (2017); global #4 in financial cards (2016)

FY2025 revenue KRW 309.2B (+30.8%); net income KRW 74.6B; market cap KRW 589.8B (Jul 2026); 354 employees

Cards

UbiVelox (KOSDAQ 089850)

Own-COS card maker; supplies BC Card annually; exports to China

—

Cards

ICK (IC Korea)

E-money and card maker; about 30% domestic e-money share (2013)

—

Cards

KONA C / KONA M (KONA I subsidiaries)

Card manufacturing arms; metal and fingerprint cards

Consolidated in KONA I

Cards (global)

Thales, IDEMIA, CPI Card Group

Global card and personalization majors

Not benchmarked

Copper winding (CTC/flat wire)

Samdong (삼동)

Cited as the only other supplier of oxygen-free CTC/copper for EHV transformers in Korea alongside TC Materials (Finance Scope, May 2025)

—

Copper / cable materials

LS Cable & System, Taihan Cable

Customers; vertically integrated cable makers

Not benchmarked

Pharma (generics)

Korean mid-size generic makers

Austin Pharm is a small player (last disclosed revenue KRW 63.7B, 2021)

Not benchmarked

Liquor payment

NHN KCP (partner) and other PG / VAN providers

Niche, regulation-created market

Not benchmarked

AMI / meters (Omni System)

Other Korean AMI vendors

Omni had about 75% digital-meter share in 2006

Historical

Peer Comparison FY2025

MetricBioSmartKONA ITC Materials

Revenue, FY2025 (KRW Bn)

482.8309.2

299.1 (standalone)

Revenue growth FY2025 (%)

-0.330.8—

Operating margin FY2025 (%)

4.69—2.27

Net income FY2025 (KRW Bn)

9.074.6—

R&D intensity (%)

0.14——

Market cap (KRW Bn)

67.9 (15 Oct 2026)

589.8 (28 Jul 2026)

171.5 (22 Jul 2026)

Dividend yield (%)

04.0—

“—” = not publicly disclosed.

Company Snapshot

$339.7M

Revenue

169

Employees

1971

Founded

Seoul, South Korea

Headquarters

SWOT Analysis

Strengths

  • Exposure to the grid capex cycle. TC Materials' power-infrastructure sales rose 73.5% YoY in 1Q26, and 1H26 revenue rose 55%.
  • Rapid consolidated operating-profit growth. Operating income went from KRW 9.8B (FY2023) to KRW 22.7B (FY2025, S&P), and 1Q26 operating income was +79% YoY.
  • Improved leverage. Net debt / EBITDA fell from 4.29x (FY2021) to 1.22x (FY2025); debt/equity from 0.88x to 0.41x.
  • Concentrated ownership with acquisition experience. The founder controls 24.72%, with a 20-year record of turnaround acquisitions (KBC, Omni, Austin, TC).
  • Tangible asset backing. Book value per share was KRW 5,883.66 (Mar-26) against a share price of KRW 2,685. Land on the balance sheet was KRW 44.4B at FY2025.
  • Customer quality at TC Materials. Customers include HD Hyundai Electric, Hyosung Heavy Industries, Iljin Electric, LS Cable, Taihan and Samsung Electronics.

Weaknesses

  • Thin margins. Gross margin was 17.7% and operating margin 4.7% in FY2025.
  • Weak cash generation. FCF was negative in 4 of 5 years (FY2021–FY2025), and TTM FCF to Mar-26 was -KRW 22.3B.
  • Volatile earnings quality. FY2024 attributable net income was only KRW 0.1B on KRW 19.5B of operating income; FY2023 profit was flattered by a KRW 15.9B investment gain.
  • Negligible R&D. R&D was 0.14% of revenue in FY2025.
  • No shareholder returns. There has been no dividend since the FY2022 cash payment, and buybacks totalled KRW 9.3M (FY2025).
  • Short-dated funding. Short-term debt was KRW 47.0B of KRW 77.7B total at Mar-26, and the quick ratio was 0.28x.

Opportunities

  • CTC capacity tripling. Monthly output reaches about 1,600 t from Oct 2026; DS Investment forecasts TC operating profit of KRW 36.7B in 2027.
  • Holding-discount unwind. At reported prices, BioSmart's 47.61% of TC Materials (TC market cap KRW 171.5B on 22 Jul 2026) is worth about KRW 82B, more than BioSmart's KRW 67.9B market cap.
  • Shareholder-return initiation. Treasury stock was eliminated in 1H26, and press scrutiny of group value-up is rising (Dealsite, Apr 2026).
  • Premium and eco cards. Metal cards in circulation more than doubled from 2018 to 2024, and policy interest in de-plastic products is growing.
  • New grid products. Superconducting wire and subsea-cable flat wire.
  • Cross-selling across education, payments and publishing. Dealsite cites the WSI Korea rationale, though the company has not articulated it.

Threats

  • Copper volatility. TC's 2Q26 operating margin fell to 3.1% from 6.3% in 1Q26 on pass-through lag.
  • Customer concentration. TC's top-3 customers were about 50% of sales, and two customers 33% (FY2025).
  • IPO credibility gap. TC Materials' FY2025 operating profit missed listing guidance by about 60%.
  • Delisting risk at affiliates. Omni System's reverse split and The Lami trading near the low-priced threshold (Dealsite, Apr 2026) both relate to stricter KOSDAQ rules on low-priced stocks.
  • Mobile-wallet substitution of physical cards. Contactless is now 92% of card shipments, but tokenized phone payments compete with plastic.
  • Governance and minority leakage. NCI rose to KRW 46.2B, and minorities absorbed KRW 4.8B of TTM profit.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
25 Apr 2025Shares rise about 10% intraday to KRW 4,120 after the then-presidential candidate Lee Jae-myung's de-plastic pledge; market highlights BioSmart's paper-panel and eco-card patentsPolicy-theme trading (Asia Economy)
15 May 20251Q25 results: revenue KRW 112.3B (-5.4% YoY), operating income KRW 5.6B (+29.7%)Soft start to FY2025
15 May 2025TC Materials lists on KOSDAQ via SPAC; power products 96.9% of its salesListed value for the core subsidiary
19 May 2025TC Materials highlights Korea-first subsea-cable flat wire; large-scale supply to HD Hyundai Electric, Samsung and LS startingProduct validation (Finance Scope)
2 Jul 2025TC Materials calls an EGM (late July) to appoint Park Hye-rin and Yoon Ho-kwon as inside directors; outside-director ratio issue flaggedGovernance (Dealsite)
14 Aug 20252Q25 results: revenue KRW 120.8B (-7.2%), operating income KRW 4.2B (-15.7%), net loss KRW 2.8BTrough quarter
14 Nov 20253Q25 results: revenue KRW 125.5B (+5.4%), operating income KRW 7.6B (+102.7%), net income KRW 4.9BRecovery begins
9 Dec 2025TC Materials publishes its 2026 IR deck (history: BioSmart M&A 2021, renamed 2024)Investor outreach
22 Dec 2025TC Materials plans to nearly double flat-wire and CTC capacity to 21,200 t in 2026; TC shares +11.7%US grid-cycle positioning
17 Feb 2026Patent granted to BioSmart (filed Jun 2025)IP (CB Insights)
19 Feb 2026TC Materials' superconducting wire national project reported near completionTechnology option
26 Feb 2026BioSmart +9.34% on the day, among the top KOSDAQ gainers on a volatile market dayMomentum (CB Insights citing news)
19 Mar 2026FY2025 business report: revenue KRW 482.8B (-0.3%), operating income KRW 22.6B (+11.5%), net income KRW 9.0B; 4Q25 revenue KRW 124.2B, operating income KRW 5.1BAnnual results
1H 2026Treasury stock (KRW 3.0B) eliminated; issued shares fall to 25.27MFirst tangible shareholder-return step (data-inferred)
9 Apr 2026Affiliate Omni System cancels treasury shares worth about KRW 1.7BGroup value-up
c. Apr 2026Park Hye-rin takes over leadership of The Lami, whose shares trade near the low-priced delisting thresholdAffiliate risk (Dealsite)
28–29 Apr 2026Dealsite series: group undervaluation and "cracks" in the M&A model; BioSmart regains WSI Korea control via loan-to-equity conversionReputational and governance scrutiny
30 Apr 2026Dealsite: Omni System approaching delisting risk as a long-term sub-KRW 1,000 stock; reverse split mootedAffiliate risk
30 Apr–1 May 2026TC Materials FY2025 standalone revenue KRW 299.1B and operating profit KRW 6.8B, versus IPO guidance of KRW 359.2B / KRW 17.9B; top-3 customers about 50% of salesIPO credibility hit
14 May 20261Q26 results: revenue KRW 145.3B (+29.4%), operating income KRW 10.1B (+79.4%), net income KRW 7.2B (+153%)Strongest quarter in the series
14 May 2026TC Materials 1Q26: revenue KRW 101.4B (+49.3%), operating profit KRW 6.4B (+169%); power infrastructure +73.5%, EV +60.1%, appliances -17.4%Driver of group growth
Jul–Sep 2026Executive/major-shareholder ownership reports (15, 24, 30 Jul; 9 Sep) and a large-holding report (12 Aug) filed–
14 Aug 20262Q26 results: revenue KRW 167.6B (+38.8%), operating income KRW 5.1B (+22.4%), net income KRW 2.2BRevenue record; margin squeeze
18 Aug 2026Shares -7.47% on 420,140 volume (about 4x average)Market reaction after 2Q26
Aug 2026TC Materials 1H26 revenue KRW 225.3B (+55%)Growth confirmed
2 Sep 2026DS Investment: TC Materials 2Q26 operating profit KRW 3.8B (+164% YoY) but margin 3.1% on copper pass-through lag; forecasts KRW 21.3B (2026) and KRW 36.7B (2027)First third-party coverage of the subsidiary
16 Sep 2026BioSmart +5.94% on 471,918 sharesUnexplained spike
Oct 2026Omni System approves 5:1 reverse split; new shares to list 20 OctAffiliate listing defense
15 Oct 2026Close KRW 2,685; down 31% from end-2025 (KRW 3,900); 6-month change -38.6% (ValueLine)De-rating despite earnings growth

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

1 chart
Income Statement: Revenue & Gross Profit: Revenue rose from KRW 189.2 Bn in FY2021 to KRW 482.8 Bn in FY2025.
BioSmart Co., Ltd. — Income Statement: Revenue & Gross Profit
Series (KRW Bn)FY2021FY2022FY2023FY2024FY2025
Revenue189.2391.8456.2484.3482.8
Gross profit68.476.77982.385.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. StockAnalysis.com (S&P Global Market Intelligence data): BioSmart income statement, balance sheet, cash flow, ratios, statistics, company profile, price history (stockanalysis.com)
  2. StockAnalysis.com: KONA I overview (stockanalysis.com)
  3. ETF Shopping (DART business-report extracts): earnings and filing register · shareholders, subsidiaries, employees, pay
  4. Butler (DART-based): segment mix, annual results, recent disclosures (butler.works)
  5. ValueLine / DataHero: business description, valuation, balance-sheet data · valueline.co.kr
  6. StockHub: price, 52-week range, analyst coverage · Omni System reverse split
  7. Investing.com: ISIN, price data (it.investing.com)
  8. Morningstar: business description, address (morningstar.com.au)
  9. Stockopedia: dividend status, revenue history (stockopedia.com)
  10. Simply Wall St: profile (CEO, former name) (simplywall.st)
  11. CB Insights: patents, news (cbinsights.com)
  12. Dealsite: BioSmart Group series (Apr–May 2026) · dealsite.co.kr · dealsite.co.kr · dealsite.co.kr · The Lami · TC Materials board (Jul 2025) · short-term borrowing (Aug 2023)
  13. Financial News / DS Investment on TC Materials (Sep 2026) (fnnews.com)
  14. Financial News / Newsis, TC Materials 1Q26 (May 2026) (fnnews.com)
  15. Hankyung, TC Materials 1Q26 (hankyung.com)
  16. Asia Economy, TC Materials capacity expansion (Dec 2025) (core.asiae.co.kr)
  17. Asia Economy, BioSmart de-plastic theme (Apr 2025) (core.asiae.co.kr)
  18. Finance Scope, TC Materials listing and products (May 2025) (finance-scope.com)
  19. TC Materials IR deck (Dec 2025) — file.alphasquare.co.kr (TC Materials company introduction, 2026)
  20. Investing.com Korea, TC Materials market cap (kr.investing.com)
  21. MyDailyByte, TC Materials 1H26 revenue (mydailybyte.com)
  22. Daily Pharm, Austin Pharm (2017, 2021, 2022) · m.dailypharm.com · dailypharm.com · m.dailypharm.com · m.dailypharm.com
  23. eToday, Omni System acquisition (2009) · Omni System IPO (2007)
  24. Newspim, Digital Genomics (2009) (newspim.com)
  25. Money Today, Park Hye-rin profile (2008) (mt.co.kr)
  26. Hankyung Magazine, Park Hye-rin profile (2016) · hanji card
  27. TheVC, Bona Networks (thevc.kr)
  28. NewsTomato, KCP liquor credit-card settlement with Bona Bank (2014) (newstomato.com)
  29. NewsTomato, Korean card makers (2013) (newstomato.com)
  30. RiskWeather, business description (riskweather.io)
  31. GII Korea (TechSci / TBRC / Grand View), smart-card market reports · giikorea.co.kr
  32. Entrust, metal cards (entrust.com)
  33. Europa Biosite acquisition of AMSBIO (2024) (manufacturingchemist.com)
  34. Medigate News / Korea Biotechnology Industry Organization, 1H26 listed bio-health results (medigatenews.com)
  35. DART filings (via ETF Shopping links): FY2025 business report rcpNo 20260319001208; 1H26 report rcpNo 20260814003659; 1Q26 rcpNo 20260514001333

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.